jrnl2103

Publication Venue For

  • Commentary: Let's get rich—The use of hydrogen-rich solution for lung preservation.  159:2119-2120. 2020
  • American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.  159:865-896. 2020
  • Cardiac surgery residency and transcatheter aortic valve replacement: “What happened to my aortic valve replacement?”.  159:215-217. 2020
  • Commentary: Basilar segmentectomy: A new weapon against cancer for the modern thoracic surgeon? 2020
  • Commentary: Will it go platinum? Microcoil localization as an adjunct to thoracoscopic wedge resection.  158:603. 2019
  • Long-term clinical outcome and graft patency of radial artery and saphenous vein grafts in multiple arterial revascularization.  158:442-450. 2019
  • Commentary: Going the distance: The effect of margin length on local recurrence after wedge resection for colorectal metastases.  157:1656-1657. 2019
  • Morbidity and 30-day mortality after decortication for parapneumonic empyema and pleural effusion among patients in the Society of Thoracic Surgeons' General Thoracic Surgery Database.  157:1288-1297.e4. 2019
  • Sternotomy for esophagectomy: Is it worth the risk?.  156:e221-e222. 2018
  • Carbon fiber: Not just for your mountain bike anymore.  156:e181-e182. 2018
  • Stem cell–derived exosomes and the failing heart: Small cause, big effect.  156:1089-1092. 2018
  • Will cardiac surgeons even turn pumpkins into carriages?.  155:1647-1649. 2018
  • Do not throw the baby with the water bath!.  154:557. 2017
  • The value of salvage surgery after stereotactic body radiotherapy failure: A sticky conundrum.  154:700-701. 2017
  • That's one small step….  153:1608. 2017
  • Building a bioartificial heart: A 3-song saga.  153:744-747. 2017
  • The regurgitant bicuspid aortic valve: Recalibrating our surgical strategies.  153:S72-S73. 2017
  • CD133+ cells: How could they have an IMPACT?.  152:1589-1591. 2016
  • Disruption of desmin-mitochondrial architecture in patients with regurgitant mitral valves and preserved ventricular function.  152:1059-1070.e2. 2016
  • Robotic lobectomy can be taught while maintaining quality patient outcomes.  152:991-997. 2016
  • The future of stem cells: Should we keep the “stem” and skip the “cells”?.  152:345-349. 2016
  • Challenging homografts as the holy grail for aortic valve endocarditis.  151:1230-1231. 2016
  • Extended criteria donors: Closer to the truth.  152:899-900. 2016
  • Lung torsion: Some answers but more questions.  152:658. 2016
  • Mock loop revelations and the calculus for recovery.  150:348-349. 2015
  • Effects of antegrade versus integrated blood cardioplegia on left ventricular function evaluated by echocardiographic real-time 3-dimensional speckle tracking.  149:877-884.e5. 2015
  • A time-related parametric risk factor analysis for postoperative atrial fibrillation after heart surgery.  149:886-892. 2015
  • Left upper lobectomy after coronary artery bypass grafting.  150:531-535. 2015
  • Predictors of contemporary coronary artery bypass grafting outcomes.  148:2720-2726.e2. 2014
  • The modern Fontan operation shows no increase in mortality out to 20 years: A new paradigm.  148:2517-2524.e1. 2014
  • Completeness of coronary revascularization and survival: Impact of age and off-pump surgery.  148:1307-1315.e1. 2014
  • Effect of severe acidosis on vasoactive effects of epinephrine and norepinephrine in human distal mammary artery.  147:1698-1705. 2014
  • Hypogammaglobulinemia after cardiopulmonary bypass in infants.  147. 2014
  • Satisfaction and compensatory hyperhidrosis rates 5 years and longer after video-assisted thoracoscopic sympathotomy for hyperhidrosis.  147. 2014
  • Optimal technique for the removal of chest tubes after pulmonary resection.  145:1535-1539. 2013
  • Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation.  145:862-868. 2013
  • Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.  146. 2013
  • Technical aspects and early results of robotic esophagectomy with chest anastomosis.  145:90-96. 2013
  • Reply to the editor.  144:1531-1533. 2012
  • Survival and quality of life at least 1 year after pneumonectomy.  144:1139-1145. 2012
  • Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?.  144:584-603. 2012
  • Mechanism of myocardial ischemia with an anomalous left coronary artery from the right sinus of Valsalva.  144:402-408. 2012
  • Association of feeding modality with interstage mortality after single-ventricle palliation.  144:173-177. 2012
  • Operative techniques in robotic thoracic surgery for inferior or posterior mediastinal pathology.  143:1138-1143. 2012
  • Venovenous extracorporeal membrane oxygenation in acute respiratory failure: Do we need a new configuration?.  143:993-994. 2012
  • Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass.  144:467-473.e2. 2012
  • Mitral valve reconstruction in Barlow disease: Long-term echographic results and implications for surgical management.  143. 2012
  • Vodka to prevent postoperative adhesions: Another unsuspected cardiac benefit of alcohol.  143:960-961. 2012
  • Consequences of mitral valve prolapse on chordal tension: Ex vivo and in vivo studies in large animal models.  142:1585-1587. 2011
  • Initial consecutive experience of completely portal robotic pulmonary resection with 4 arms.  142:740-746. 2011
  • Survival after resection of synchronous non-small cell lung cancer.  142:547-553. 2011
  • Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves.  142:238-239. 2011
  • Perceptions regarding cardiothoracic surgical training at Veterans Affairs hospitals.  141:1107-1113. 2011
  • Optimal care of patients with non-small cell lung cancer reduces perioperative morbidity.  141:22-33. 2011
  • Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.  140:225-232. 2010
  • General thoracic surgery is safe in patients taking clopidogrel (Plavix).  140:970-976. 2010
  • Infection after implantation of pulsatile mechanical circulatory support devices.  139. 2010
  • Effect of sympathectomy level on the incidence of compensatory hyperhidrosis after sympathectomy for palmar hyperhidrosis.  138:581-585. 2009
  • The analysis of a prospective surgical database improves postoperative fast-tracking algorithms after pulmonary resection.  137:1173-1179. 2009
  • The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure.  137:1012-1019. 2009
  • Concomitant giant coronary artery and coronary sinus aneurysms.  137:763-765. 2009
  • Change in maximum standardized uptake value on repeat positron emission tomography after chemoradiotherapy in patients with esophageal cancer identifies complete responders.  137:605-609. 2009
  • Is botulinum toxin injection of the pylorus during Ivor-Lewis esophagogastrectomy the optimal drainage strategy?.  137:565-572. 2009
  • Successful cardiac transplant after Berlin Heart bridge in a single ventricle heart: Use of aortopulmonary shunt as a supplementary source of pulmonary blood flow.  137. 2009
  • Reply to the Editor:.  136:798. 2008
  • Rigid bronchoscopy and surgical resection for broncholithiasis and calcified mediastinal lymph nodes.  136:186-190. 2008
  • Cardiac stem cells in the real world.  135:673-678. 2008
  • Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study.  135:261-268. 2008
  • Results of a prospective algorithm to remove chest tubes after pulmonary resection with high output.  135:269-273. 2008
  • Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation.  133:1078-1084. 2007
  • Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device.  133:517-524. 2007
  • The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.  132:1363-1368. 2006
  • Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure.  132:124-131. 2006
  • Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.  131:352-356. 2006
  • Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: A prospective study.  131:1229-1235. 2006
  • Intercostal muscle flap reduces the pain of thoracotomy: A prospective randomized trial.  130:987-993. 2005
  • Long-term survival in lung transplant recipients after successful preoperative coronary revascularization.  130:538-541. 2005
  • Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1α.  130:173-179. 2005
  • The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.  129:1232-1241. 2005
  • Left ventricular assist devices as destination therapy: A new look at survival.  129:9-17. 2005
  • The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.  130:151-159. 2005
  • Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study.  125:881-890. 2003
  • Modulation of mitochondrial adenosine triphosphate-sensitive potassium channels and sodium-hydrogen exchange provide additive protection from severe ischemia-reperfusion injury.  125:863-871. 2003
  • Amiodarone in cardiothoracic surgery patients: What is a surgeon to do?.  125:463-464. 2003
  • Improving outcomes for women after coronary artery bypass grafting: A case for prevention.  126:1704-1706. 2003
  • Pulmonary transplantation for advanced bronchioloalveolar carcinoma.  125:45-48. 2003
  • Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.  122:1186-1195. 2001
  • Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na+/H+ exchange inhibition: Which is the best protective strategy for heart transplants?.  121:155-162. 2001
  • Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function.  119:1169-1175. 2000
  • Controlled postcardioplegia reperfusion: Mechanism for attenuation of reperfusion injury.  119:1093-1101. 2000
  • Prophylactic value of preincision intra-aortic balloon pump: Analysis of a statewide experience.  120:1112-1119. 2000
  • Platypnea and orthodeoxia: Shunting associated with an aortic aneurysm.  113:955-956. 1997
  • Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation.  113:202-209. 1997
  • Coronary vascular regulation during postcardioplegia reperfusion.  112:1054-1063. 1996
  • Ischemic preconditioning in cardiac surgery: A word of caution.  112:1378-1386. 1996
  • Acadesine: A new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study.  110:1096-1106. 1995
  • Cardiac transplant coronary artery disease: A multivariable analysis of pretransplantation risk factors for disease development and morbid events.  109:1081-1089. 1995
  • Preconditioning with potassium channel openers:. A new concept for enhancing cardioplegic protection?.  110:1606-1614. 1995
  • Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass.  110:774-785. 1995
  • Xanthine oxidase inactivation attenuates postocclusion shock after descending thoracic aorta occlusion and reperfusion in rabbits.  110:715-722. 1995
  • A potential mechanism of vasodilation after warm heart surgery: The temperature-dependent release of cytokines.  107:293-299. 1994
  • Effect of hemoglobin concentration on oxyhemoglobin dissociation during hypothermic blood cardioplegic arrest.  108:664-671. 1994
  • Invited letter concerning: Acute interstitial nephritis in a cardiac transplant recipient receiving ciprofloxacin.  107:1364-1365. 1994
  • Reply to the Editor.  107:1366-1367. 1994
  • Xanthine oxidoreductase release after descending thoracic aorta occlusion and reperfusion in rabbits.  107:1222-1227. 1994
  • Duration of asystolic reperfusion and reperfusate electrolyte composition influence postcardioplegia ventricular fibrillation.  106:511-519. 1993
  • Improved recovery of heart transplants with a specific kit of preservation solutions.  105:353-363. 1993
  • Invited letter concerning: Cytokines and mechanisms of capillary leakage after cardiopulmonary bypass [6].  106:566-567. 1993
  • Invited letter concerning: Transplantation tolerance and transplantation [6].  105:184-185. 1993
  • Long-term function of cryopreserved aortic homografts: A ten-year study.  106:154-166. 1993
  • Outcomes in neonatal pulmonary atresia with intact ventricular septum: A multiinstitutional study.  105:406-427. 1993
  • Invited letter concerning: Changes in plasma-free thyroid hormones during cardiopulmonary bypass [1].  104:526-527. 1992
  • Maintenance of the myocardial thiol pool by N-acetylcysteine: An effective means of improving cardioplegic protection.  103:936-944. 1992
  • Quantitation of mapping uncertainty in Wolff-Parkinson-White syndrome: Implications for anatomic characterization and surgical division of accessory atrioventricular connections.  104:1045-1052. 1992
  • Transesophageal echocardiographic diagnosis of multicentric left ventricular myxomas mimicking a left atrial tumor.  103:471-474. 1992
  • Wolff-Parkinson-White syndrome: A quantitative morphometric analysis of surgical anatomy.  104:802-811. 1992
  • Case report: Circulatory support for seventy days with resolution of acute heart failure [2].  102:932-934. 1991
  • Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.  101:432-445. 1991
  • Routine use of intraoperative epicardial echocardiography and Doppler color flow imaging to guide and evaluate repair of congenital heart lesions. A prospective study..  100:297-309. 1990
  • High alveolar surface tension pulmonary edema--relationship to adult respiratory distress syndrome..  100:145-146. 1990
  • A promising approach for improving the recovery of heart transplants. Prevention of free radical injury through iron chelation by deferoxamine.  100:13-21. 1990
  • Changes in triiodothyronine during cardiopulmonary bypass: A clinical problem? (I: Reply).  100:465. 1990
  • Continuous arteriovenous hemodialysis for acute renal failure after cardiac operations.  99:175-176. 1990
  • Invited letter concerning: High alveolar surface tension pulmonary edema - Relationship to adult respiratory distress syndrome (I).  100:145. 1990
  • Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.  99:716-724. 1990
  • The role of ABO blood group compatibility in heart transplantation between closely related animal species. An experimental study using the vervet monkey to baboon cardiac xenograft model.  97:447-455. 1989
  • Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man.  96:582-589. 1988
  • Effect of triiodothyronine (T3) on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass: An experimental study in baboons.  96:600-607. 1988
  • The effects of cardioplegic potassium concentration and myocardial temperature on electrical activity in the heart during elective cardioplegic arrest.  92:755-765. 1986
  • Have the results of mitral valve replacement improved?.  92:186-197. 1986
  • Cryosurgical modification of retrograde atrioventricular conduction: Implications for the surgical treatment of atrioventricular nodal reentry tachycardia.  91:826-834. 1986
  • The effects of brain death and 24 hours' storage by hypothermic perfusion on donor heart function in the pig.  91:896-909. 1986
  • The effects of retrograde perfusion of cardioplegic solutions in cardiac operations..  92:457-458. 1986
  • A comparative study of free radical scavengers in cardioplegic solutions. Improved protection with peroxidase.  92:264-271. 1986
  • Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates.  90:235-242. 1985
  • An asanguineous reperfusion solution. An effective adjunct to cardioplegic protection in high-risk valve operations.  88:278-286. 1984
  • Alteration of antegrade atrioventricular conduction by cryoablation of peri-atrioventricular nodal tissue: Implications for the surgical treatment of atrioventricular nodal reentry tachycardia.  88:67-75. 1984
  • Supraventricular conduction abnormalities following cardiac operations. A complication of inadequate atrial preservation.  85:105-115. 1983
  • Changes in indications for heart transplantation. An additional argument for the preservation of the recipient's own heart.  84:716-726. 1982
  • Elective prolongation of atrioventricular conduction by multiple discrete cryolesions. A new technique for the treatment of paroxysmal supraventricular tachycardia.  84:554-559. 1982
  • Encircling endocardial ventriculotomy for refractory ischemic ventricular tachycardia. I. Electrophysiological effects.  83:840-849. 1982
  • Encircling endocardial ventriculotomy for refractory ischemic ventricular tachycardia. II. Effects on regional myocardial blood flow.  83:850-856. 1982
  • Encircling endocardial ventriculotomy for refractory ischemic ventricular tachycardia. III. Effects on regional left ventricular function.  83:857-864. 1982
  • Orthotopic transplantation of the baboon heart after 20 to 24 hours' preservation by continuous hypothermic perfusion with an oxygenated hyperosmolar solution.  83:133-140. 1982
  • The present status of heterotopic cardiac transplantation.  81:433-439. 1981
  • Familial cardiac myxoma. Emphasis on unusual clinical manifestations.  77:782-788. 1979
  • In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.  73:189-194. 1977
  • A simple method of resuscitation and short term preservation of the canine cadaver heart.  70:896-908. 1975